Skip to main content

FETAX Assay for Evaluation of Developmental Toxicity

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1641))

Abstract

The frog embryo teratogenesis assay Xenopus (FETAX) test is a development toxicity screening test. Due to the small amount of compound needed and the capability to study organogenesis in a short period of time (96 h), FETAX test constitutes an efficient development toxicity alert test when performed early in drug safety development. The test is conducted on fertilized Xenopus laevis mid-blastula-stage eggs over the organogenesis period. Compound teratogenic potential is determined after analysis of the mortality and malformation observations on larvae. In parallel, FETAX test provides also information concerning embryotoxic effect based on larva length.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. ASTM (1998) Standard guide for conducting the frog embryo teratogenesis assay – Xenopus. Designation E 1439-98, Annual book of ASTM standards, vol 11.5. American Society for Testing and Materials, Philadelphia, pp 825–836

    Google Scholar 

  2. Bantle JA, Finch RA, Burton DT, Fort DJ, Dawson DA, Linder G, Rayburn JR, Hull M, Kumsher-King M, Gaudet-Hull AM, Turley SD (1996) FETAX interlaboratory validation study: Phase III – Part 1 testing. J Appl Toxicol 16(6):517–528

    Article  CAS  PubMed  Google Scholar 

  3. Leconte I, Mouche I (2013) Frog embryo teratogenesis assay on Xenopus and predictivity compared with in vivo mammalian studies. Methods Mol Biol 947:403–421

    Article  CAS  PubMed  Google Scholar 

  4. ASTM (2012) Standard guide for conducting the frog embryo teratogenesis assay – Xenopus Designation E 1439-12, ASTM book of standards, vol 11.6. American Society for Testing and Materials, Philadelphia

    Google Scholar 

  5. Sipe CW, Saha MS (2007) The use of microarray technology in non mammalian vertebrate systems. In: Rampal JB (ed) Microarrays: volume II: applications and data analysis, Methods in Molecular Biology, vol 382. Humana, Totowa, NJ, pp 1–16

    Google Scholar 

  6. Vallée M, Aiba K, Piao Y, Palin MF, Ko MS, Sirard MA (2008) Comparative analysis of oocyte transcript profiles reveals a high degree of conservation among species. Reproduction 135(4):439–448

    Article  PubMed  Google Scholar 

  7. Bantle JA, Dumont JN, Finch RA, Linder G, Fort DJ (1998) Atlas of abnormalities, a guide for the performance of FETAX, 2nd edn. Oklahoma State University, Stillwater, OK

    Google Scholar 

  8. Fort DJ, Stover EL, Bantle JA, Rayburn JR, Hull MA, Finch RA, Burton DT, Turley SD, Dawson DA, Linder G, Buchwalter D, Dumont JN, Kumsher-King M, Gaudet-Hull AM (1998) Phase III interlaboratory study of FETAX, Part 2: interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay-Xenopus (FETAX). Drug Chem Toxicol 21(1):1–14

    Article  CAS  PubMed  Google Scholar 

  9. Bantle JA, Finch RA, Fort DJ, Stover EL, Hull M, Kumsher-King M, Gaudet-Hull AM (1999) Phase III interlaboratory study of FETAX, Part 3: FETAX validation using 12 compounds with and without an exogenous metabolic activation system. J Appl Toxicol 19:447–472

    Article  CAS  PubMed  Google Scholar 

  10. Fort DJ, Rogers RL, Stover EL, Finch RA (2001) Optimization of an exogenous metabolic activation system for FETAX. I. Post-isolation rat liver microsome mixtures. Drug Chem Toxicol 24(2):103–115

    Article  CAS  PubMed  Google Scholar 

  11. Fort DJ, Rogers RL, Paul RR, Stover EL, Finch RA (2001) Optimization of an exogenous metabolic activation system for FETAX. II. Preliminary evaluation. Drug Chem Toxicol 24(2):117–127

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Isabelle Mouche .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this protocol

Cite this protocol

Mouche, I., Malésic, L., Gillardeaux, O. (2017). FETAX Assay for Evaluation of Developmental Toxicity. In: Gautier, JC. (eds) Drug Safety Evaluation. Methods in Molecular Biology, vol 1641. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7172-5_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7172-5_17

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-7170-1

  • Online ISBN: 978-1-4939-7172-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics